A. Chowdhary, N. Jex, S. Kotha, M. Giannoudi, S. Thirunavukarasu, S. Plein, H. Procter, Sevval Akkaya, E. Levelt, P. Kellman, J. Greenwood
{"title":"2型糖尿病患者接受胰高血糖素样肽-1受体激动剂(利拉鲁肽)治疗后心肌应激灌注和能量改善——一项随机、单中心、开放标签、交叉药物试验","authors":"A. Chowdhary, N. Jex, S. Kotha, M. Giannoudi, S. Thirunavukarasu, S. Plein, H. Procter, Sevval Akkaya, E. Levelt, P. Kellman, J. Greenwood","doi":"10.1136/heartjnl-2023-bcs.168","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":34850,"journal":{"name":"Imaging","volume":" ","pages":""},"PeriodicalIF":0.7000,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"168 Myocardial stress perfusion and energetics improves in patients with type 2 diabetes after treatment with a glucagon like peptide-1 receptor agonist (liraglutide)- a randomised, single centre, open label, cross-over drug trial\",\"authors\":\"A. Chowdhary, N. Jex, S. Kotha, M. Giannoudi, S. Thirunavukarasu, S. Plein, H. Procter, Sevval Akkaya, E. Levelt, P. Kellman, J. Greenwood\",\"doi\":\"10.1136/heartjnl-2023-bcs.168\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":34850,\"journal\":{\"name\":\"Imaging\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":0.7000,\"publicationDate\":\"2023-06-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Imaging\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1136/heartjnl-2023-bcs.168\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"MEDICINE, GENERAL & INTERNAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Imaging","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1136/heartjnl-2023-bcs.168","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
168 Myocardial stress perfusion and energetics improves in patients with type 2 diabetes after treatment with a glucagon like peptide-1 receptor agonist (liraglutide)- a randomised, single centre, open label, cross-over drug trial